Monday, October 1, 2018

VelosBio Finds $58M

San Diego-based VelosBio, a biotech startup developing novel antibody-drug conjugates to treat hematological cancers and solid tumours, has raised $58M in a funding round. The Series A funding was led by Arix Bioscience, and also included Pappas Ventures, Chiesi Ventures, Takeda Ventures, and Decheng Capital. Lead investor Arix said the funding will be

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.